The immunocytological analysis, covering the entire patient cohort including both APL and non-APL AML, reveals that CD34-/dim was very common, observed in 13 patients, while HLA-DR-/dim was also considerably frequent, identified in 8 patients. Here, CD34 is linked to acute promyelocytic leukemia.